Sage Journals: Discover world-class research

Abstract

We describe a 58-year old female patient with rapid development of arterial and venous thromboembolisms, including deep vein thrombosis (DVT) in the lower limbs, recurrent cerebral infarctions and bilateral pulmonary emboli. Her laboratory data on admission showed positive anticardiolipin antibody of IgG isotype (IgG aCL) and positive anti-β2 glycoprotein-I antibody of IgG isotype (IgG aβ₂-GPI), and decreased protein C activity and protein S antigen. Systemic examinations revealed the presence of an ovarian cancer. Surgical resection was attempted, but her cancer infiltrated the pelvic wall and could not be resected. Despite treatment with unfractionated heparin followed by warfarin, she died due to recurrent episodes of cerebral infarction.

This case was considered as probable catastrophic antiphospholipid syndrome (CAPS), which might be associated with ovarian cancer. Known as Trousseau's syndrome, arterial and, more commonly, venous thrombosis is a frequent complication of cancer and sometimes a harbinger of occult cancer. Our case indicates that there is an overlap between antiphospholipid syndrome (APS) and Trousseau's syndrome. It is important to bear in mind that a thrombotic event associated with cancer can be the first manifestation of CAPS.

Keywords

catastrophic antiphospholipid syndrome malignancies ovarian cancer recurrent cerebral infarctions Trousseau's syndrome

Get full access to this article

View all access options for this article.

References

Wilson WA , Gharavi AE , Koike T et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop . Arthritis Rheum 1999; 42: 1309–1311 .

Asherson RA.

A “primary” antiphospholipid syndrome?

J Rheumatol 1988; 15: 1742–1746 .

Pierangeli SS , Girardi G , Vega-Ostertag M , Liu X , Espinola RG , Salmon J . Requirement of activation of complement C3 and C5 for antiphospholipid antibody-mediated thrombophilia . Arthritis Rheum 2005; 52: 2120–2124 .

Asherson RA. The catastrophic antiphospholipid syndrome . J Rheumatol 1992; 19: 508–512 .

Asherson RA. Multiorgan failure and antiphospholipid antibodies: the catastrophic antiphospholipid (Asherson's) syndrome . Immunobiology 2005; 210: 727–733 .

Cervera R , Piette JC , Font J et al. Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients . Arthritis Rheum 2002; 46: 1019–1027 .

Asherson RA , Cervera R , de Groot PG et al. Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines . Lupus 2003; 12: 530–534 .

Rickles FR , Edwards RL . Activation of blood coagulation in cancer: Trousseau's syndrome revisited . Blood 1983; 62: 14–31 .

Rickles FR , Levine M , Edwards RL . Hemostatic alterations in cancer patients . Cancer Metastasis Rev 1992; 11: 237–248 .

10.

Tasi SH , Juan CJ , Dai MS , Kao WY . Trousseau's syndrome related to adenocarcinoma of the colon and cholangiocarcinoma . Eur J Neurol 2004; 11: 493–496 .

11.

Sallah S , Wan JY , Nguyen NP . Venous thrombosis in patients with solid tumors: determination of frequency and characteristics . Thromb Haemost 2002; 87: 575–579 .

12.

Zuckerman E , Toubi E , Golan TD et al. Increased thromboembolic incidence in anti-cardiolipin-positive patients with malignancy . Br J Cancer 1995; 72: 447–451 .

13.

Gomez-Puerta JA , Cervera R , Espinosa G et al. Antiphospholipid antibodies associated with malignancies: clinical and pathological characteristics of 120 patients . Semin Arthritis Rheum 2006; 35: 322–332 .

14.

Egan RM , Munn RK . Catastrophic antiphospholipid antibody syndrome presenting with multiple thromboses and sites of avascular necrosis . J Rheumatol 1994; 21: 2376–2379 .

15.

Ruffatti A , Aversa S , Del Ross T , Tonetto S , Fiorentino M , Todesco S . Antiphospholipid antibody syndrome associated with ovarian cancer. A new paraneoplastic syndrome? J Rheumatol 1994; 21: 2162–2163 .

16.

Bessis D , Sotto A , Viard JP , Berard M , Ciurana AJ , Boffa MC . Trousseau's syndrome with nonbacterial thrombotic endocarditis: pathogenic role of antiphospholipid syndrome . Am J Med 1995; 98: 511–513 .

17.

Keung YK , Cobos E , Meyerrose GE , Roberson GH . Progressive thrombosis after treatment of diffuse large cell non-Hodgkin's lymphoma and concomitant lupus anticoagulant . Leuk Lymphoma 1996; 20: 341–345 .

18.

Messiaen T , Lefebvre C , Lambert M . Case report: thoracic aorta thrombus with systemic embolization: a rare paraneoplastic antiphospholipid syndrome? Am J Med Sci 1996; 312: 303–305 .

19.

Onida P , Tresoldi M , Rugarli C . Anti-phospholipid-antibody syndrome associated with peripheral T-cell lymphoma . Am J Hematol 1997; 55: 167–168 .

20.

Piette JC , Amoura Z , Foucher-Lavergne A . “Catastrophic” diagnosis of the antiphospholipid syndrome . Ann Intern Med 1999; 131: 798–799 .

21.

Yoshida J , Iwai T , Mayumi T et al. [A patient operated for occlusion of the superior mesenteric artery] . Nippon Geka Gakkai Zasshi 1999; 100: 228–230 .

22.

Soltesz P , Szekanecz Z , Vegh J et al. Catastrophic antiphospholipid syndrome in cancer . Haematologia (Budap) 2000; 30: 303–311 .

23.

Katsuoka H , Mimori Y , Kohriyama T et al. [An autopsy case of catastrophic antiphospholipid syndrome presenting with recurrent multiple cerebral infarction associated with lung cancer] . No To Shinkei 2000; 52: 64–69 .

24.

Yamamoto T , Ito M , Nagata S et al. Catastrophic exacerbation of antiphospholipid syndrome after lung adenocarcinoma biopsy . J Rheumatol 2000; 27: 2035–2037 .

25.

Aranguren A , Perez-Salazar M , Paramo JA , Zozaya J , Rocha E . Antiphospholipid antibodies, portal and mesenteric thrombosis and carcinoid tumor: a case report . Thromb Haemost 2001; 86: 1334-1334 .

26.

Asherson RA , Cervera R , Piette JC et al. Catastrophic antiphospholipid syndrome: clues to the pathogenesis from a series of 80 patients . Medicine (Baltimore) 2001; 80: 355–377 .

27.

Espiritu JD , Creer MH , Miklos AZ , Bajaj MS . Fatal tumor thrombosis due to an inferior vena cava leiomyosarcoma in a patient with antiphospholipid antibody syndrome . Mayo Clin Proc 2002; 77: 595–599 .

28.

Langer F , Eifrig B , Marx G , Stork A , Hegewisch-Becker S , Hossfeld DK . Exacerbation of antiphospholipid antibody syndrome after treatment of localized cancer: a report of two cases . Ann Hematol 2002; 81: 727–731 .

29.

Moll S , Kudrik FJ , Thomas DB . Catastrophic antiphospholipid antibody syndrome . Am J Hematol 2003; 72: 278–279 .

30.

Orsino A , Schneider R , DeVeber G et al. Childhood acute myelomonocytic leukemia (AML-M4) presenting as catastrophic antiphospholipid antibody syndrome . J Pediatr Hematol Oncol 2004; 26: 327–330 .

31.

Ozaki M , Ogata M , Yokoyama T , Kawasaki T , Shigematsu A , Sata T . Prevention of thrombosis with prostaglandin E1 in a patient with catastrophic antiphospholipid syndrome . Can J Anaesth 2005; 52: 143–147 .

32.

Cervera R , Font J , Gomez-Puerta JA et al. Validation of the preliminary criteria for the classification of catastrophic antiphospholipid syndrome . Ann Rheum Dis 2005; 64: 1205–1209 .

33.

Erkan D , Yazici Y , Peterson MG , Sammaritano L , Lockshin MD . A cross-sectional study of clinical thrombotic risk factors and preventive treatments in antiphospholipid syndrome . Rheumatology (Oxford) 2002; 41: 924–929 .

34.

Bucciarelli S , Espinosa G , Cervera R et al. Mortality in the catastrophic antiphospholipid syndrome: Causes of death and prognostic factors in a series of 250 patients . Arthritis Rheum 2006; 54: 2568–2576 .

35.

Malnick SD , Geltner D , Sthoeger Z . Anticardiolipin antibody associated with renal carcinoma . J Rheumatol 1995; 22: 2007–2008 .

Catastrophic antiphospholipid syndrome associated with malignancies (case report and review of the literature)

Abstract

Keywords

Get full access to this article

References